Background: Dengue-associated hemophagocytic lymphohistiocytosis (DA-HLH) is a rare but severe hyperinflammatory complication of dengue. Its clinical overlap with severe dengue often delays recognition. We describe the clinical, laboratory and therapeutic characteristics of pediatric patients with DA-HLH in a dengue-endemic region of Latin America. Methods: We conducted a retrospective cohort study of pediatric patients diagnosed with DA-HLH at a tertiary-care center in Cali, Colombia, between 2013 and 2024. HLH was diagnosed using HLH-2004 criteria and supported by the HScore. Clinical features, laboratory parameters, treatment regimens and outcomes were analyzed. Associations between extreme biomarker values (below Q1 or above Q3) and mortality were assessed using Fisher exact test. Results: Nineteen patients were included, with a median age of 7 years. Fever and cytopenias were present in all cases, and hepatomegaly was frequently observed. Hyperferritinemia occurred in nearly all patients. Viral coinfections—most commonly Epstein–Barr virus and cytomegalovirus—were identified in over one-third of cases. Overall mortality was 21.1% and occurred exclusively among patients with significant underlying comorbidities. In this exploratory analysis, elevated total bilirubin was the only laboratory parameter associated with mortality. Conclusions: DA-HLH should be considered in pediatric patients with dengue who present with persistent fever, cytopenias, hepatic dysfunction and marked hyperferritinemia. In this exploratory analysis, elevated bilirubin appeared to reflect severe systemic and hepatic involvement rather than an independent prognostic factor, while viral coinfections may contribute to disease severity. Early recognition and individualized immunomodulatory management are essential, and larger multicenter studies are needed to validate these findings.
Antecedentes: Las alergias afectan al 25% de la población mundial. El diagnóstico preciso es decisivo para evitar restricciones innecesarias e implementar estrategias de medicina de precisión adaptada a las necesidades específicas de cada paciente. Objetivo: Este manual establece directrices claras para los principales procedimientos clínicos en alergología, detallando sus indicaciones, rendimiento diagnóstico y aplicabilidad en el contexto latinoamericano. Métodos: La Asociación Colombiana de Alergia, Asma e Inmunología (ACAAI) realizó una exhaustiva revisión de la literatura para compilar los procedimientos más utilizados en la práctica clínica de la alergología. Se proporcionan recomendaciones específicas para cada procedimiento, incorporando pautas operativas, precisión diagnóstica e indicaciones clínicas. Además, este manual fue revisado por alergólogos de diversos países latinoamericanos para garantizar su aplicabilidad regional. Resultados: Se formularon recomendaciones fundamentadas en la evidencia y viables operativamente para la ejecución e interpretación de nueve procedimientos clave en alergología: 1) pruebas de punción cutánea, 2) pruebas intradérmicas, 3) pruebas epicutáneas, 4) pruebas de provocación nasal, 5) pruebas de provocación oral, 6) pruebas de provocación para urticarias inducibles, 7) desensibilización a fármacos, 8) inducción de tolerancia a alimentos e 9) inmunoterapia con alérgenos. El documento fue validado por alergólogos de Ecuador, México y Perú, quienes confirmaron su relevancia y aplicabilidad en sus prácticas clínicas. Conclusión: Este documento de posición proporciona un manual de directrices prácticas basadas para la ejecución e interpretación de procedimientos en alergología. Su implementación mejorará la precisión diagnóstica y terapéutica, garantizando un abordaje seguro y efectivo en el tratamiento de las enfermedades alérgicas en América Latina. Palabras claves: Alergia; Diagnóstico; Latinoamérica; Colombia; Asma; Alergólogos; Pruebas intraepidérmicas; Pruebas de parche; Pruebas de provocación nasal; Urticaria; Inducción a la tolerancia; Alérgenos; Inmunoterapia; Ecuador; México, perú; Enfermedad.
1 November 2026 in Allergologia et Immunopathologia
Background: Eosinophilic esophagitis (EoE) is a chronic immune-mediated esophageal disease with increasing incidence worldwide, although pediatric data from Latin America remain limited. Methods: We conducted a retrospective longitudinal descriptive study including patients aged 0–18 years diagnosed with EoE between 2013 and 2023 at a tertiary referral center in Colombia. Diagnosis was based on compatible clinical manifestations and histologic confirmation on esophageal biopsy. Demographic, clinical, histologic, and allergen sensitization profiles, as well as treatment response and endoscopic follow-up, were analyzed descriptively. Results: Seventy-five patients were included, with a median age of 10 years, and 65% were male. The most frequent symptoms were persistent gastroesophageal reflux (53%), recurrent abdominal pain (51%), and vomiting (32%). Allergic comorbidities were frequent, predominantly allergic rhinitis and asthma. Among patients who underwent follow-up endoscopy (68%), clinical and histologic remission were observed in 59% and 39%, respectively. Conclusions: This pediatric cohort demonstrated a substantial atopic burden and a heterogeneous therapeutic response. The discordance between clinical and histologic remission underscores the importance of structured endoscopic follow-up. These findings provide region-specific data that may inform multidisciplinary management strategies in pediatric EoE.